Where is Modella located?

Modella is headquartered in Boston, United States.

How many employees does Modella have?

As of Sep 30, 2026, the latest employee count at Modella is 6.

Where does Modella rank among its competitors?

Modella ranks 20th amongst 239 active competitors, of which 72 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was DeepWise, which secured an undisclosed amount in Jun, 2026.

Who are the top competitors of Modella?

Modella's top competitors include PathAI, Aiforia and Proscia. Among them, DeepWise secured the most recent funding round in June, 2026.

Modella - 2026 Company Profile, Team & Competitors

Company Details

Developer of artificial intelligence for biomedical imaging, enhancing diagnostic workflows. The company creates AI models integrating multimodal biomarker data for diagnostic and therapeutic improvements. It offers AI systems empowering healthcare professionals in assessing complex biomedical patient data. The focus is on identifying novel biomarkers to improve patient outcomes.

Website: www.modella.ai
Social
Email ID: *****@modella.ai

Key Metrics

Founded Year

2024

Location

Boston, United States

Stage

Acquired

Ranked

20^th among 239 active competitors

Employee Count

6 as on Sep 30, 2026

Similar Companies

OpenEvidence & 3101 more

Exit Details

Acquired by AstraZeneca (Jan 13, 2026)

View Modella's full profile

Modella got acquired by AstraZeneca on Jan 13, 2026.

Click here to take a look at Modella's acquisition in detail

Modella has not raised any funding rounds yet.

The founders of Modella is Long Phi Le.

Here are the details of Modella's key team members:

Long Phi Le: Co-Founder, Scientific Advisor of Modella and founder of 1 other company.
Contact Info: 1 email address

View details of Modella's Founder profiles and Board Members

Modella's employee count trend

Modella has 6 employees as of Sep 26. Here is Modella's employee count trend over the years:

Uncover Modella's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Modella include PathAI, Aiforia and Proscia. Here is the list of Top 10 competitors of Modella, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	PathAI 2016, Boston (United States), Series C	Provider of digital pathology image management system for clinical labs	$255M	General Catalyst, General Atlantic & 22 others	72/100
2nd	Aiforia 2014, Helsinki (Finland), Public	Provider of an AI and cloud-based, deep learning image analysis platform in all therapy areas	$23M	Ascend Capital Partners, Businessfinland & 8 others	66/100
3rd	Proscia 2014, Philadelphia (United States), Acquired	Provider of an AI and cloud-based digital pathology solution for cancer diagnosis	$129M	Triangle Peak Partners, TEDCO & 22 others	62/100
4th	Techcyte 2014, Orem (United States), Series B	Artificial intelligence (AI) based image analysis platform for pathologists	$50.4M	ARUP Laboratories, Zoetis & 2 others	62/100
5th	Nucle AI 2017, Chicago (United States), Series B	AI-assisted platform for image analysis	$60M	Vertex Ventures Israel, Sanofi Ventures & 9 others	61/100
6th	Aignostics 2018, Berlin (Germany), Series B	Developer of artificial intelligence software for biomedical image analysis applications	$53.9M	Wellington Partners Venture Capital, Boehringer Ingelheim Venture Fund ... & 9 others	61/100
7th	DeepWise 2017, Beijing (China), Series D	Developer of AI-based radiology image solutions primarily for cancer diagnosis	$115M	Legend Capital, CICC Capital & 18 others	59/100
8th	Mindpeak 2017, Hamburg (Germany), Series A	Provider of AI-based pathological analysis platform	$18.3M	IFB Innovationsstarter, ZEISS & 28 others	59/100
9th	Onc.ai 2020, San Carlos (United States), Series A	AI-based cancer treatment and diagnosis platform for healthcare providers	$31M	Accomplice, MassMutual & 12 others	57/100
10th	HistoIndex 2010, Singapore (Singapore), Series A	Provider of AI powered digital pathology platform for fibrosis analysis	$6.89M	OCBC, SEEDS Capital & 2 others	57/100
20th	Modella 2024, Boston (United States), Acquired	Developer of artificial intelligence for biomedical imaging, enhancing diagnostic workflows	-	-	51/100